Real-World Data on the Prevalence of Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer in the Middle East and North Africa

Real-World Data on the Prevalence of Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer in the Middle East and North Africa

PURPOSEAnaplastic lymphoma kinase (ALK) gene alterations are potent oncogenic drivers in non–small-cell lung cancer (NSCLC). Tyrosine kinase inhibitors targeting the ALK pathway are effective in treating ALK-positive NSCLC. Around 5% of Asian and White patients with NSCLC have ALK-positive tumors, b...

Full description

Bibliographic Details
Main Authors: Abdul Rahman Jazieh, Rabab Gaafar, Hassan Errihani, Hassan Jaafar, Fouad Al Dayel, Abeer A. Bahnassy, Hatem El Kadi, Mohamed Magdy Abdallah, Ghazi Zaatari
Format: Article
Language:English
Published: American Society of Clinical Oncology 2021-12-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.21.00067

Internet

https://ascopubs.org/doi/10.1200/GO.21.00067

Similar Items